EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access

Impact of Mean Blood Pressure Profiles in Percutaneous Left Ventricular Assist Device‐Supported High‐Risk Percutaneous Coronary Intervention: The PROTECT III Study

Guillaume Bonnet, Karl-Philipp Rommel iD, Batla Falah iD, Alexandra J Lansky iD, Yiran Zhang iD, Michael J Schonning iD, Björn Redfors iD, Daniel Burkhoff iD, David J Cohen iD, M Babar Basir iD, William W O'Neill iD, Juan F Granada iD

Journal of the American Heart Association · 2025

DOI: 10.1161/jaha.124.036367 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of the American Heart Association, 2025. Verfasst von Guillaume Bonnet und 11 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovacular Research Foundation New York NY USA. Hauptthemen laut MEDLINE: Heart-Assist Devices, Percutaneous Coronary Intervention, Blood Pressure, Hypotension. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background Percutaneous left ventricular assist devices are used prophylactically to prevent hypotension during high‐risk percutaneous coronary intervention. However, the impact of preprocedural hemodynamic profiles on procedural and clinical outcomes in these patients is unknown. Methods and Results Patients from the central venous access device PROTECT III registry (NCT04136392) were categorized according to preprocedural mean blood pressure (MBP). Procedural and in‐hospital outcomes, including hypotensive episodes, need for prolonged percutaneous left ventricular assist device support, and in‐hospital death, were compared between groups. We also assessed the relationship between preprocedural MBP and 90‐day major adverse cardiovascular and cerebrovascular events, which included all‐cause death, myocardial infarction, stroke/transient ischemic attack, and repeat revascularization, as well as with 1‐year mortality. A total of 1159 patients underwent percutaneous left ventricular assist device‐supported high‐risk percutaneous coronary intervention and were stratified into 4 hemodynamic profiles of preprocedural MBP level: MBP>100 mm Hg (n=242), >90 to ≤100 mm Hg (n=264), >80 to ≤90 mm Hg (n=306), and ≤80 mm Hg (n=347). Lower preprocedural MBP was associated with baseline anemia, history of heart failure, left main disease, and transfer from another hospital. In‐hospital and procedural adverse outcomes did not differ between the BP categories. However, 90‐day major adverse cardiovascular and cerebrovascular events rates and 1‐year mortality increased with decreasing baseline BP levels. The association between BP category and 1‐year mortality remained significant after adjustment for other factors (hazard ratio [HR], 0.79 [95% CI, 0.71–0.88], P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart-Assist DevicesPercutaneous Coronary InterventionBlood PressureHypotensionHeart FailureVentricular Function, LeftCoronary Artery DiseaseHumansMaleFemaleMiddle AgedAgedRegistriesRisk FactorsTreatment OutcomeHospital MortalityRisk AssessmentTime Factors

Stichwörter der Autor:innen

PROTECT IIIblood pressure controlhigh‐risk percutaneous coronary interventionmean arterial pressuretemporary left ventricular assist device support

Autor:innen und Institutionen

  • Cardiovacular Research Foundation New York NY USA.
  • Medico-Surgical Department Hopital Cardiologique Haut-Lévêque, Bordeaux University Hospital Bordeaux France.
  • Department of Cardiology Heart Center at University of Leipzig and Leipzig Heart Institute Leipzig Germany.
  • Department of Cardiology Yale School of Medicine New Haven CT USA.
  • Barts Heart Centre London and Queen Mary University of London London United Kingdom.
  • Department of Population Health Sciences Weill Cornell Medicine New York NY USA.

ORCID-Profile: Karl-Philipp Rommel, Batla Falah, Alexandra J Lansky, Yiran Zhang, Michael J Schonning, Björn Redfors, Daniel Burkhoff, David J Cohen, M Babar Basir, William W O'Neill, Juan F Granada

Zitieren

APA

Bonnet, G., Rommel, K. P., Falah, B., Lansky, A. J., Zhang, Y., Schonning, M. J., Redfors, B., Burkhoff, D., Cohen, D. J., Basir, M. B., O'Neill, W. W., & Granada, J. F. (2025). Impact of Mean Blood Pressure Profiles in Percutaneous Left Ventricular Assist Device‐Supported High‐Risk Percutaneous Coronary Intervention: The PROTECT III Study. Journal of the American Heart Association. https://doi.org/10.1161/jaha.124.036367

Vancouver

Bonnet G, Rommel KP, Falah B, Lansky AJ, Zhang Y, Schonning MJ, et al. Impact of Mean Blood Pressure Profiles in Percutaneous Left Ventricular Assist Device‐Supported High‐Risk Percutaneous Coronary Intervention: The PROTECT III Study. Journal of the American Heart Association. 2025. doi:10.1161/jaha.124.036367

BibTeX
@article{Bonnet2025,
  author = {Bonnet, Guillaume and Rommel, Karl-Philipp and Falah, Batla and Lansky, Alexandra J and Zhang, Yiran and Schonning, Michael J and Redfors, Björn and Burkhoff, Daniel and Cohen, David J and Basir, M Babar and O'Neill, William W and Granada, Juan F},
  title = {Impact of Mean Blood Pressure Profiles in Percutaneous Left Ventricular Assist Device‐Supported High‐Risk Percutaneous Coronary Intervention: The PROTECT III Study},
  journal = {Journal of the American Heart Association},
  year = {2025},
  doi = {10.1161/jaha.124.036367}
}
Kostenlos starten →